Islam Baiev

1.7k total citations · 1 hit paper
12 papers, 336 citations indexed

About

Islam Baiev is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Islam Baiev has authored 12 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Islam Baiev's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Fibroblast Growth Factor Research (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Islam Baiev is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Fibroblast Growth Factor Research (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Islam Baiev collaborates with scholars based in United States, France and United Kingdom. Islam Baiev's co-authors include Ryan B. Corcoran, Jochen K. Lennerz, Chendi Li, W. Marston Linehan, Lesli A. Kiedrowski, Aaron N. Hata, Mohammed U. Syed, Liron Bar‐Peled, Samuel J. Klempner and Noritaka Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Islam Baiev

10 papers receiving 331 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

2021 302 citations Noritaka Tanaka, W. Marston Linehan et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Islam Baiev United States	5	239	143	78	55	32	12	336
Mustafa Sakhi United States	2	230 1.0×	176 1.2×	94 1.2×	55 1.0×	28 0.9×	3	365
Besnik Qeriqi United States	3	274 1.1×	177 1.2×	95 1.2×	57 1.0×	28 0.9×	5	381
Alberto Vides United States	3	298 1.2×	173 1.2×	85 1.1×	47 0.9×	25 0.8×	4	384
Chuanchuan Li United States	3	297 1.2×	169 1.2×	84 1.1×	46 0.8×	26 0.8×	4	390
T. Trang United States	2	247 1.0×	153 1.1×	76 1.0×	38 0.7×	22 0.7×	2	322
Mohammed U. Syed United States	2	233 1.0×	126 0.9×	73 0.9×	50 0.9×	26 0.8×	5	311
Hajrah Khawaja United Kingdom	7	147 0.6×	115 0.8×	57 0.7×	54 1.0×	41 1.3×	8	272
Nadia Vié France	7	201 0.8×	164 1.1×	54 0.7×	105 1.9×	35 1.1×	10	362
Ramona Wullenkord Germany	5	234 1.0×	129 0.9×	80 1.0×	54 1.0×	48 1.5×	7	331
Mei Hua Jin South Korea	7	201 0.8×	232 1.6×	76 1.0×	61 1.1×	28 0.9×	11	367

Countries citing papers authored by Islam Baiev

Since Specialization

Citations

This map shows the geographic impact of Islam Baiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam Baiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam Baiev more than expected).

Fields of papers citing papers by Islam Baiev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Islam Baiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam Baiev. The network helps show where Islam Baiev may publish in the future.

Co-authorship network of co-authors of Islam Baiev

This figure shows the co-authorship network connecting the top 25 collaborators of Islam Baiev. A scholar is included among the top collaborators of Islam Baiev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Islam Baiev. Islam Baiev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Michael, Lindsay M. Hannan, Lipika Goyal, et al.. (2024). Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma—a real-world, multicenter study. Therapeutic Advances in Medical Oncology. 16. 12741821–12741821. 1 indexed citations

Saraf, Anurag, Islam Baiev, Emily E. Van Seventer, et al.. (2023). Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer. JAMA Network Open. 6(11). e2343512–e2343512. 5 indexed citations

Konstantinidou, Eirini, et al.. (2023). Prevalence and Clinicopathologic Characteristics of Hypercalcemia in Patients With Cholangiocarcinoma. JAMA Oncology. 9(5). 714–714. 1 indexed citations

Sridharan, Vishwajith, Azfar Neyaz, Islam Baiev, et al.. (2022). FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures. Clinical Cancer Research. 28(24). 5431–5439. 9 indexed citations

Tian, Jun, Jonathan Chen, Sherry Chao, et al.. (2022). Abstract LB003: Combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients: Correlative studies from a phase 2 trial. Cancer Research. 82(12_Supplement). LB003–LB003. 1 indexed citations

Saraf, Anurag, Islam Baiev, Amirkasra Mojtahed, et al.. (2022). Changes in Functional Assessment of Cancer Therapy: General (FACT-G) to predict treatment response and survival outcomes in patients with metastatic gastrointestinal (GI) cancer.. Journal of Clinical Oncology. 40(16_suppl). 6570–6570. 1 indexed citations

Corcoran, Ryan B., Ju Tian, J. Chen, et al.. (2022). SO-38 Clinical efficacy and single-cell analysis of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients. Annals of Oncology. 33. S373–S373.

Tanaka, Noritaka, W. Marston Linehan, Chendi Li, et al.. (2021). Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation. Cancer Discovery. 11(8). 1913–1922. 302 indexed citations breakdown →

Baiev, Islam, Emily E. Van Seventer, Amirkasra Mojtahed, et al.. (2021). Changes in patient-reported outcomes (PROs) and tumor markers (TMs) to predict treatment response and survival in patients with metastatic gastrointestinal (GI) cancer.. Journal of Clinical Oncology. 39(28_suppl). 154–154. 1 indexed citations

10.

Goyal, Lipika, Ángela Lamarca, John H. Strickler, et al.. (2020). The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).. Journal of Clinical Oncology. 38(15_suppl). e16686–e16686. 9 indexed citations

11.

Goyal, Lipika, Islam Baiev, Karen Zhang, et al.. (2020). Acquired resistance to selective FGFR inhibitors in FGFR-altered cholangiocarcinoma. European Journal of Cancer. 138. S21–S22. 1 indexed citations

12.

Boilève, Alice, Islam Baiev, Nora Horick, et al.. (2019). Clinical and molecular features of patients with cholangiocarcinoma harboring FGFR genetic alterations.. Journal of Clinical Oncology. 37(15_suppl). 4084–4084. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact